Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Cosmo Pharmaceuticals N.V.    COPN   NL0011832936

COSMO PHARMACEUTICALS N.V.

(COPN)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M € Estimates in M €
Fiscal Period December 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Sales 67,7 67,2 65,6 47,1 90,9 86,1
EBITDA 27,7 -6,06 -12,1 -12,8 3,03 19,6
Operating profit (EBIT) 24,6 -15,5 -16,6 -17,4 -8,55 14,2
Pre-Tax Profit (EBT) 27,5 -32,4 -17,5 -28,9 -5,70 18,2
Net income 19,3 -32,4 -18,1 -27,6 -10,9 9,60
P/E ratio 115x -57,1x -65,0x -36,0x -90,9x 199x
EPS ( € ) 1,37 -2,19 -1,20 -1,84 -0,73 0,33
Dividend per Share ( € ) 1,50 1,50 - - - 0,75
Yield 0,95% 1,20% - - - 1,13%
Reference price ( € ) 157,991 125,040 78,046 66,385 66,385 66,385
Announcement Date 03/24/2017
07:00am
03/26/2018
05:00am
03/29/2019
05:08am
- - -
Finances - Leverage
Actuals in M € Estimates in M €
Fiscal Period December 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Debt - - - - - -
Finance 161 168 191 117 95,0 146
Operating income (EBITDA) 27,7 -6,06 -12,1 -12,8 3,03 19,6
Leverage
(Debt/EBITDA)
- - - - - -
Capital Expenditure 1,83 12,3 1,90 7,20 6,00 2,95
Free Cash Flow (FCF) 7,98 -22,3 -12,1 -21,1 -11,2 3,00
Book Value Per Share (BVPS) ( € ) 29,5 31,7 29,9 27,2 26,0 25,3
Cash Flow per Share (  ) - - -0,68 - - -
Announcement Date 03/24/2017
07:00am
03/26/2018
05:00am
03/29/2019
05:08am
- - -
Balance Sheet Analysis
Assessed data source
© 2019 S&P Global Market Intelligence
Financial Ratios

Size 2019e 2020e
Capitalization 965 M € -
Entreprise Value (EV) 848 M € 870 M €
Valuation 2019e 2020e
P/E ratio (Price / EPS) -36,0x -90,9x
Capitalization / Revenue 20,5x 10,6x
EV / Revenue 18,0x 9,33x
EV / EBITDA -66,4x 280x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 2,44x 2,55x
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) -37,0% -9,40%
Operating Leverage (Delta EBIT / Delta Sales) -0,17x 0,55x
Net Margin (Net Profit / Revenue) -58,6% -12,0%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) -7,00% 14,0%
Rate of Dividend - -
Balance Sheet Analysis 2019e 2020e
CAPEX / Sales   15,3% 6,60%
Cash Flow / Sales - -
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) - -
EPS & Dividend